Rhodes Jason P insider trades
Rhodes Jason P has filed 29 Form 4s with the SEC that we hold, for Dyne Therapeutics, Inc. (DYN) (Director), GBIO (Director), Disc Medicine, Inc. (GMTX) (Director, 10% owner) and Replimune Group, Inc. (REPL) (Director). Across all of them we count 1 purchase worth $10.0M and 127 sales worth $178.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 79 sales ($129.1M). The largest single trade was a sale of 1,359,674 shares of Dyne Therapeutics, Inc. worth $34.0M, dated 2026-08-14. The first filing on our record is dated 2021-09-24 and the latest 2026-08-17.
Dyne Therapeutics, Inc. (DYN)
Director · 20 filings · 115 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-12 | P, purchase reported on Form 4 | 934,581 | $10.0M | 2022-12-14 |
| 2024-02-15 | S, sale reported on Form 4 | 2,113 | $51.7K | 2024-02-20 |
| 2024-02-15 | S, sale reported on Form 4 | 175,793 | $4.2M | 2024-02-20 |
| 2024-02-16 | S, sale reported on Form 4 | 162,707 | $3.8M | 2024-02-20 |
| 2024-02-20 | S, sale reported on Form 4 | 166,029 | $3.8M | 2024-02-20 |
| 2024-02-20 | S, sale reported on Form 4 | 3,510 | $82.1K | 2024-02-20 |
| 2024-02-21 | S, sale reported on Form 4 | 35,164 | $813.7K | 2024-02-23 |
| 2024-02-21 | S, sale reported on Form 4 | 149,337 | $3.4M | 2024-02-23 |
| 2024-02-22 | S, sale reported on Form 4 | 119,360 | $2.7M | 2024-02-23 |
| 2024-02-23 | S, sale reported on Form 4 | 23,648 | $536.8K | 2024-02-23 |
| 2024-02-23 | S, sale reported on Form 4 | 13,738 | $311.9K | 2024-02-23 |
| 2024-02-23 | S, sale reported on Form 4 | 159,542 | $3.6M | 2024-02-23 |
| 2024-02-26 | S, sale reported on Form 4 | 136,312 | $3.2M | 2024-02-28 |
| 2024-02-26 | S, sale reported on Form 4 | 64,783 | $1.6M | 2024-02-28 |
| 2024-02-26 | S, sale reported on Form 4 | 20,205 | $476.6K | 2024-02-28 |
| 2024-02-26 | S, sale reported on Form 4 | 9,603 | $230.3K | 2024-02-28 |
| 2024-02-26 | S, sale reported on Form 4 | 11,736 | $276.9K | 2024-02-28 |
| 2024-02-26 | S, sale reported on Form 4 | 5,580 | $133.8K | 2024-02-28 |
| 2024-02-27 | S, sale reported on Form 4 | 272,923 | $6.7M | 2024-02-28 |
| 2024-02-27 | S, sale reported on Form 4 | 25,779 | $636.2K | 2024-02-28 |
| 2024-02-27 | S, sale reported on Form 4 | 40,455 | $986.3K | 2024-02-28 |
| 2024-02-27 | S, sale reported on Form 4 | 2,216 | $54.7K | 2024-02-28 |
| 2024-02-27 | S, sale reported on Form 4 | 3,821 | $94.3K | 2024-02-28 |
| 2024-02-27 | S, sale reported on Form 4 | 23,505 | $573.1K | 2024-02-28 |
| 2024-02-28 | S, sale reported on Form 4 | 360 | $9.1K | 2024-02-28 |
| 2024-02-28 | S, sale reported on Form 4 | 13,109 | $325.5K | 2024-02-28 |
| 2024-02-28 | S, sale reported on Form 4 | 210 | $5.3K | 2024-02-28 |
| 2024-02-28 | S, sale reported on Form 4 | 22,567 | $560.3K | 2024-02-28 |
| 2024-02-28 | S, sale reported on Form 4 | 2,430 | $61.4K | 2024-02-28 |
| 2024-02-28 | S, sale reported on Form 4 | 152,244 | $3.8M | 2024-02-28 |
| 2024-03-01 | S, sale reported on Form 4 | 17,099 | $513.8K | 2024-03-05 |
| 2024-03-01 | S, sale reported on Form 4 | 29,435 | $884.5K | 2024-03-05 |
| 2024-11-14 | S, sale reported on Form 4 | 583 | $19.3K | 2024-11-18 |
| 2024-11-14 | S, sale reported on Form 4 | 4 | $132 | 2024-11-18 |
| 2024-11-14 | S, sale reported on Form 4 | 123 | $4.1K | 2024-11-18 |
| 2024-11-14 | S, sale reported on Form 4 | 72 | $2.4K | 2024-11-18 |
| 2026-04-20 | S, sale reported on Form 4 | 56,368 | $1.1M | 2026-04-22 |
| 2026-04-20 | S, sale reported on Form 4 | 1,401 | $28.1K | 2026-04-22 |
| 2026-04-20 | S, sale reported on Form 4 | 142,604 | $2.9M | 2026-04-22 |
| 2026-04-20 | S, sale reported on Form 4 | 71,676 | $1.4M | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 15 | $301 | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 1,530 | $30.7K | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 769 | $15.4K | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 56,228 | $1.1M | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 1,398 | $27.3K | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 142,253 | $2.8M | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 71,499 | $1.4M | 2026-04-22 |
| 2026-04-21 | S, sale reported on Form 4 | 605 | $12.1K | 2026-04-22 |
| 2026-04-22 | S, sale reported on Form 4 | 59,663 | $1.2M | 2026-04-22 |
| 2026-04-22 | S, sale reported on Form 4 | 1,485 | $29.2K | 2026-04-22 |
| 2026-04-22 | S, sale reported on Form 4 | 150,942 | $3.0M | 2026-04-22 |
| 2026-04-22 | S, sale reported on Form 4 | 75,866 | $1.5M | 2026-04-22 |
| 2026-04-23 | S, sale reported on Form 4 | 15,148 | $290.7K | 2026-04-27 |
| 2026-04-23 | S, sale reported on Form 4 | 377 | $7.2K | 2026-04-27 |
| 2026-04-23 | S, sale reported on Form 4 | 38,322 | $735.4K | 2026-04-27 |
| 2026-04-23 | S, sale reported on Form 4 | 19,261 | $369.6K | 2026-04-27 |
| 2026-04-24 | S, sale reported on Form 4 | 72,310 | $1.3M | 2026-04-27 |
| 2026-04-24 | S, sale reported on Form 4 | 710 | $13.1K | 2026-04-27 |
| 2026-04-24 | S, sale reported on Form 4 | 28,583 | $528.2K | 2026-04-27 |
| 2026-04-24 | S, sale reported on Form 4 | 36,345 | $671.7K | 2026-04-27 |
| 2026-04-27 | S, sale reported on Form 4 | 45,709 | $829.6K | 2026-04-27 |
| 2026-04-27 | S, sale reported on Form 4 | 90,943 | $1.7M | 2026-04-27 |
| 2026-04-27 | S, sale reported on Form 4 | 35,947 | $652.4K | 2026-04-27 |
| 2026-04-27 | S, sale reported on Form 4 | 894 | $16.2K | 2026-04-27 |
| 2026-04-28 | S, sale reported on Form 4 | 26 | $494 | 2026-04-30 |
| 2026-04-28 | S, sale reported on Form 4 | 52 | $988 | 2026-04-30 |
| 2026-04-28 | S, sale reported on Form 4 | 1 | $19 | 2026-04-30 |
| 2026-04-28 | S, sale reported on Form 4 | 47,082 | $865.4K | 2026-04-30 |
| 2026-04-28 | S, sale reported on Form 4 | 1,170 | $21.5K | 2026-04-30 |
| 2026-04-28 | S, sale reported on Form 4 | 21 | $399 | 2026-04-30 |
| 2026-04-28 | S, sale reported on Form 4 | 59,870 | $1.1M | 2026-04-30 |
| 2026-04-28 | S, sale reported on Form 4 | 119,115 | $2.2M | 2026-04-30 |
| 2026-05-04 | S, sale reported on Form 4 | 61 | $1.1K | 2026-05-06 |
| 2026-05-04 | S, sale reported on Form 4 | 2,466 | $44.4K | 2026-05-06 |
| 2026-05-04 | S, sale reported on Form 4 | 3,136 | $56.4K | 2026-05-06 |
| 2026-05-04 | S, sale reported on Form 4 | 6,241 | $112.3K | 2026-05-06 |
| 2026-05-05 | S, sale reported on Form 4 | 3,056 | $55.1K | 2026-05-06 |
| 2026-05-05 | S, sale reported on Form 4 | 6,081 | $109.6K | 2026-05-06 |
| 2026-05-05 | S, sale reported on Form 4 | 60 | $1.1K | 2026-05-06 |
| 2026-05-05 | S, sale reported on Form 4 | 2,403 | $43.3K | 2026-05-06 |
| 2026-05-06 | S, sale reported on Form 4 | 21,926 | $398.6K | 2026-05-06 |
| 2026-05-06 | S, sale reported on Form 4 | 43,621 | $793.0K | 2026-05-06 |
| 2026-05-06 | S, sale reported on Form 4 | 428 | $7.8K | 2026-05-06 |
| 2026-05-06 | S, sale reported on Form 4 | 17,244 | $313.5K | 2026-05-06 |
| 2026-06-23 | S, sale reported on Form 4 | 30,774 | $650.3K | 2026-06-26 |
| 2026-06-23 | S, sale reported on Form 4 | 77,855 | $1.6M | 2026-06-26 |
| 2026-06-23 | S, sale reported on Form 4 | 39,131 | $826.8K | 2026-06-26 |
| 2026-06-24 | S, sale reported on Form 4 | 19,973 | $419.8K | 2026-06-26 |
| 2026-06-24 | S, sale reported on Form 4 | 25,397 | $533.8K | 2026-06-26 |
| 2026-06-24 | S, sale reported on Form 4 | 50,530 | $1.1M | 2026-06-26 |
| 2026-06-25 | S, sale reported on Form 4 | 6,382 | $134.7K | 2026-06-26 |
| 2026-06-25 | S, sale reported on Form 4 | 12,699 | $267.9K | 2026-06-26 |
| 2026-06-25 | S, sale reported on Form 4 | 5,019 | $105.9K | 2026-06-26 |
| 2026-06-26 | S, sale reported on Form 4 | 162,954 | $3.5M | 2026-06-30 |
| 2026-06-26 | S, sale reported on Form 4 | 81,903 | $1.7M | 2026-06-30 |
| 2026-06-26 | S, sale reported on Form 4 | 64,411 | $1.4M | 2026-06-30 |
| 2026-06-29 | S, sale reported on Form 4 | 102,969 | $2.2M | 2026-06-30 |
| 2026-06-29 | S, sale reported on Form 4 | 40,702 | $860.4K | 2026-06-30 |
| 2026-06-29 | S, sale reported on Form 4 | 51,756 | $1.1M | 2026-06-30 |
| 2026-07-06 | S, sale reported on Form 4 | 253,039 | $5.8M | 2026-07-08 |
Newest 100 of 115
GBIO
Director · 7 filings · 13 purchases and sales
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-22 | S, sale reported on Form 4 | 57 | $1.5K | 2021-09-24 |
| 2021-09-22 | S, sale reported on Form 4 | 30,560 | $791.2K | 2021-09-24 |
| 2021-09-23 | S, sale reported on Form 4 | 1 | $27 | 2021-09-24 |
| 2021-09-23 | S, sale reported on Form 4 | 140 | $3.7K | 2021-09-24 |
| 2021-09-23 | S, sale reported on Form 4 | 75,324 | $2.0M | 2021-09-24 |
| 2021-09-24 | S, sale reported on Form 4 | 28,862 | $745.8K | 2021-09-24 |
| 2021-09-24 | S, sale reported on Form 4 | 54 | $1.4K | 2021-09-24 |
| 2021-09-27 | S, sale reported on Form 4 | 51,294 | $1.3M | 2021-09-29 |
| 2021-09-27 | S, sale reported on Form 4 | 95 | $2.4K | 2021-09-29 |
| 2021-09-28 | S, sale reported on Form 4 | 13,089 | $330.4K | 2021-09-29 |
| 2021-09-28 | S, sale reported on Form 4 | 24 | $606 | 2021-09-29 |
| 2021-09-29 | S, sale reported on Form 4 | 30 | $738 | 2021-09-29 |
| 2021-09-29 | S, sale reported on Form 4 | 16,556 | $407.1K | 2021-09-29 |
Disc Medicine, Inc. (GMTX)
Director, 10% owner · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Replimune Group, Inc. (REPL)
Director · 1 filing · 0 purchases and sales
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 1577014) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms